Special items: Ovarian Cancer and Us blog best viewed in Firefox

Wednesday, July 15, 2009

UPDATE: FDA Panel Rejects JNJ's (ovarian cancer) Yondelis; Doxil Expansion

Article - WSJ.com: "UPDATE: FDA Panel Rejects JNJ's Yondelis; Doxil Expansion"

No comments:

Post a Comment

Your comments?

Note: Only a member of this blog may post a comment.